Radiology-Diagnostic·Brooklyn, NY

SUNY Downstate Health Sciences University

Signal lift23%65%+42 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
234–262
p10 – p90
Sample N
865
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.9%
8 of 148 applicants
01Cohort funnelthis cycle
N = 865
Applied
865
100.0%
Invited
148
17.1%
Class size
8
0.9%
J-1 visaAdvanced
Your fitSUNY Downstate Health Sciences University Program

Create a free profile to see your personalized fit

Get started
Contact
RO
Program Director
Rhonda Osborne, MD, MPH
Email director
NS
Program Coordinator
Nicole Snead, MPA
Email coordinator
Training sites4 hospitals · Brooklyn
  • 1
    NYC Health + Hospitals/Kings County
    Brooklyn, NY
    Primary
  • 2
    SUNY Downstate Health Science University
    Brooklyn, NY
    Sponsor
  • 3
    Veterans Affairs Medical Center (Brooklyn)
    Brooklyn, NY
    Participant
  • 4
    University Hospital-SUNY Health Science Center at Brooklyn
    Brooklyn, NY
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK234262
180205230255280

Level 2 CE data not available

Interview rates
US MD
23%
US DO
12%
US IMG
17%
Non-US IMG
6%
Signal rates
Gold
38%
Silver
24%
None
14%
Applicant origin
In-state
66%
Out-of-state
11%
Interview prepRadiology-Diagnostic
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add SUNY Downstate Health Sciences University to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiology-Diagnostic.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.